J. A. WREN

A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the<scp>J</scp>anus kinase inhibitor oclacitinib (<scp>A</scp>poquel^®) in client‐owned dogs with atopic dermatitis

Sallie B. Cosgrove, J. A. WREN, Dawn M. Cleaver et al. · Veterinary Dermatology · 2013 · 135 citations · Full text

Atopic Dermatitis, Chronic Ad, Clinical Trials +10

Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis

Sallie B. Cosgrove, J. A. WREN, Dawn M. Cleaver et al. · Veterinary Dermatology · 2013 · 125 citations · Full text

Long‐term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life

Sallie B. Cosgrove, Dawn M. Cleaver, Vickie L. King et al. · Veterinary Dermatology · 2015 · 95 citations · Full text

Central neural peptides and catecholamines in spontaneous and DOCA/salt hypertension

Mariana Morris, J. A. WREN, David K. Sundberg · Peptides · 1981 · 54 citations

Hypertension, Adrenal Gland, Central Neural Peptides +15

An evaluation of dirlotapide to reduce body weight of client‐owned dogs in two placebo‐controlled clinical studies in Europe

J. Gossellin, Jo McKelvie, J. Sherington et al. · Journal of Veterinary Pharmacology and Therapeutics · 2007 · 29 citations